In short
The landmark award, valued at up to USD 170 million, will lead to 18 million doses of the RTS,S vaccine being available over the next three years, potentially saving thousands of young lives annually. The RTS,S malaria vaccine – the result of 35 years of research and development – is the first-ever vaccine against a parasitic disease.
GSK Contracted to Produce World’s First Malaria Vaccine Top story
17 Aug 2022, 10:50 Comments 1256 Views Kampala, Uganda Education Report
IP: 18.232.31.206. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.